Business
CB Scientific’s (CBSC) R & D Focuses on Opioid Crisis, a National Public Health Emergency
CB Scientific’s (CBSC) R & D Focuses on Opioid Crisis, a National Public Health Emergency.
About this update from Cardiac Biotech Solutions Inc.
[{"type":"text","content":"Denver, CO, Oct. 31, 2017 (GLOBE NEWSWIRE) -- CB Scientific, Inc. (OTC PINK: CBSC), a designer, developer and manufacturer of Cannabis Analytical Tools and Devices, Cannabis Medical Delivery Systems and Personal Analytical Kits and Devices. The company has developed three core platform technologies; CannaRAPID™, CannaNASAL™, and CannaDERME™, focused on precise dosing and controlled release of cannabinoid compounds for patients. CB Scientific announces today that the Company’s 2018 R & D goals focused on products and technologies to address opioid crisis.President Trump on October 26 directed the Department of Health and Human Services to declare the opioid crisis a public health emergency, taking long-anticipated action to address a rapidly escalating epidemic of drug use. United States is in the middle of an unprecedented opioid epidemic; Since 2000, the rate of overdose deaths involving opioids nearly quadrupled, and over 165,000 people have died from prescription opioid overdoses. Prevention, treatment, and research to rapidly tackle and reverse opioid overdoses are critical to fighting this epidemic.Studies have shown that phyto-cannabinoids like Cannabidiol have promising results in opioid withdrawal symptoms and heroin-seeking behavior. CB Scientific’s studies have shown that Cannabidiol can have promising improvements in opioid withdrawal symptoms by attenuating the rewarding effects of opioids. CB Scientific has been developing various cannabinoid delivery technologies and state-of-the art smart medical devices for relieving various pains and opioid withdrawal symptoms. There is strong evidence that cannabinoid compounds can relieve from depression caused by drug addiction. CB Scientific is partnering with opioid addiction centers and clinical practitioners to conduct studies on the use of PainPatchTM for opioid addiction.“Data is showing that on an average day in US about 140 people die from an opioid-related overdose, most of the ones died belongs to the younger population” said Bobban Subhadra, M.S., Ph.D, Chief Operating Officer of CB Scientific. “This is a serious epidemic that need to be dealt with a high level of urgency; we are talking about teens who are the future of our nation dying in high numbers on our streets. That is the reason, why we at CB Scientific, wanted to seriously inv...